Vivos management to present at 11:30 am Eastern Time on March 16, 2021
Colorado, March 1, 2021
Vivos Therapeutics, Inc. (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered breathing, including mild to moderate obstructive sleep apnea (OSA), today announced that Kirk Huntsman, Chief Executive Officer, Brad Amman, Chief Financial Officer and Ed Loew, Investor Relations Officer, will conduct meetings with investors at the 33rd Annual ROTH Conference, to be held virtually from March 15-17, 2021.
Institutional investors interested in one-on-one meetings with Vivos management should contact their ROTH Capital institutional sales representative.
Vivos Therapeutics, Inc. will be presenting at the conference on Tuesday, March 16, 2021 at 11:30 am Eastern Time. Investors interested in joining the Vivos presentation can register at the link below:
The conference will feature presentations from public and private companies across a variety of industry sectors. During previous events, ROTH has hosted close to 550 participating companies and attracted more than 5,000 attendees, including institutional investors, analysts, family offices and high-net-worth investors.
A replay of the presentation will be available for view following the presentation on Vivos’ website at: https://vivoslife.com/investor-relations/